Physician

Laura A Teasley, MD

According to 2025 Medicare claims, Laura Teasley, MD (NPI: 1154312635) practices ophthalmology in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is EYE MEDICAL CLINIC OF FRESNO, INC (NPI: 1306853452; TIN: 942179577) and primary practice location at 93720-3326.

Teasley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 743 traditional Medicare patients, billed 29,168 HCPCS/CPT codes, and received $2,303,640 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 368 prescription claims across 78 beneficiaries totaling $17,747 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 13 records totaling $711. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $2,411,697 and ending at $2,303,640. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $12,492 to $17,747. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2015 Medicare payment: $2,411,697 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,434,670 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,359,110 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,608,211 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $883,623 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,342,791 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,149,472 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,008,991 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,393,698 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,303,640 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155099,950$2,411,697
201672812,555$3,434,670
20173716,784$1,359,110
20188208,344$1,608,211
20197706,181$883,623
20207147,192$1,342,791
20217488,492$2,149,472
20227738,298$2,008,991
202370120,681$2,393,698
202474329,168$2,303,640

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$31K2015 Drug cost: $12,492 (USD; Tot_Drug_Cst)2016 Drug cost: $6,064 (USD; Tot_Drug_Cst)2017 Drug cost: $8,226 (USD; Tot_Drug_Cst)2018 Drug cost: $9,523 (USD; Tot_Drug_Cst)2019 Drug cost: $28,477 (USD; Tot_Drug_Cst)2020 Drug cost: $17,334 (USD; Tot_Drug_Cst)2021 Drug cost: $22,619 (USD; Tot_Drug_Cst)2022 Drug cost: $30,551 (USD; Tot_Drug_Cst)2023 Drug cost: $21,923 (USD; Tot_Drug_Cst)2024 Drug cost: $17,747 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201564223$12,492
201648165$6,064
201749221$8,226
201852177$9,523
201976251$28,477
202070257$17,334
202175256$22,619
202286363$30,551
202366340$21,923
202478368$17,747

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2871,241$94
92014Established patient complete exam of visual system381466$85
92012Established patient problem focused exam of visual system224318$58
92134Imaging of retina6422,028$29
92250Photography of the retina227292$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate892,387$2,949
Bromfenac SodiumBromfenac Sodium14441$2,086
Brimonidine TartrateBrimonidine Tartrate261,047$1,546
LatanoprostLatanoprost613,871$571
Atropine SulfateAtropine Sulfate12458$361

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$711Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Laura A. Teasley, MD?

Tedicare shows public-source Medicare data for Laura A. Teasley, MD (NPI 1154312635), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laura A. Teasley, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Laura A. Teasley, MD?

Laura A. Teasley, MD is linked to EYE MEDICAL CLINIC OF FRESNO, INC (billing NPI 1306853452) in the available physician profile data.

Does Laura A. Teasley, MD have Open Payments data?

Laura A. Teasley, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.